Clot-busting drug alteplase shows promise for stroke treatment up to 24 hours after onset

The clot-dissolving medication, alteplase, improved stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2025.

AI Agents in Healthcare: Retaining Talent, Improving Patient Care

Dan Parsons, co-founder and Chief Product Officer at Thoughtful The aging population is creating an unprecedented demand for healthcare services while the available healthcare workforce is declining. Meanwhile, the healthcare system continues to rely heavily on

September 16, 2024

CDC Proposes ‘Morning After’ Pill to Prevent STIs

The CDC has moved to recommend doxycycline post-exposure prophylaxis (PEP) for gay and bisexual men and transgender women to prevent sexually transmitted infections (STIs). With

October 4, 2023

Merck KGaA bags another molecular glue deal for $16M upfront, this time with C4

In the latest development in the “highly dynamic” molecular glue space, Merck KGaA has inked a discovery agreement with C4 Therapeutics for two protein degraders

March 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.